esonarimod has been researched along with Rheumatoid Arthritis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, H; Hirose, Y; Ichino, M; Mihara, S; Miura, K; Nagafuchi, H; Ochi, T; Sakane, T; Suzuki, N; Tomita, T; Wakisaka, S | 1 |
| Higaki, M; Inoue, T; Mizushima, Y; Takahashi, S | 1 |
| Higaki, M; Inoue, T; Yamashita, M | 1 |
| Aoyagi, T; Eguchi, K; Fukuda, T; Hida, A; Hirai, Y; Honda, S; Ida, H; Kamachi, M; Kawabe, Y; Kawakami, A; Kita, M; Migita, K; Oizumi, K; Origuchi, T; Shibatomi, K; Yamasaki, S | 1 |
4 other study(ies) available for esonarimod and Rheumatoid Arthritis
| Article | Year |
|---|---|
Mechanisms of KE298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cell Division; Cells, Cultured; Collagenases; Gene Expression; Humans; Interleukin-6; Matrix Metalloproteinase 1; Phenylpropionates; Polymerase Chain Reaction; RNA, Messenger; Synovial Membrane; Transcription Factor AP-1; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1997 |
Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Dinoprostone; Humans; Interleukin-6; Metalloendopeptidases; Phenylpropionates; Protease Inhibitors; Synovial Membrane; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 1998 |
The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis.
Topics: Aged; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Base Sequence; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Disease Models, Animal; Electrophoresis; Female; Humans; Interleukin-1; Male; Middle Aged; Molecular Sequence Data; Phenylpropionates; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Synovial Membrane | 2001 |
Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Enzyme Precursors; Gelatinases; Humans; Interleukin-1; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Phenylpropionates; RNA, Messenger; Synovial Membrane; Tissue Inhibitor of Metalloproteinase-2; Transcriptional Activation | 2001 |